United States - Evaluation of Abuse Potential of Synthetic Opioids and Other Depressants Using In Vivo Pharmacological Studies
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 17 May 2024
- Opportunity publication date
- 19 April 2024
- Value of contract
- to be confirmed
- Your guide to exporting
Description
EA Diversion Control Division (DC), Drug and Chemical Evaluation Section is responsible for evaluating drugs and chemicals to determine whether these substances have abuse potential of synthetic opioid. The contractor shall provide DEA with investigational study results and a description of the methodology used to conduct the investigation in the form of a study.
- Opportunity closing date
- 17 May 2024
- Value of contract
- to be confirmed
About the buyer
- Address
- HEADQUATERS UNITED STATES
- Contact
- darrell.goodwin@dea.gov
Bid for tender
If your company meets the requirements of the tender, go to the website where the tender is hosted and submit your bid.
This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.
Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.